id int64 | detection_setting string | facility_id string | facility_type string | patient_age_years int64 | patient_age_group string | patient_sex string | patient_pregnant int64 | original_diagnosis string | sf_medicine_class string | sf_classification string | sf_confirmed_by_testing int64 | sf_source string | harm_type string | severity string | hospitalised int64 | hospital_days int64 | ICU_admission int64 | permanent_disability int64 | death int64 | treatment_failure int64 | time_to_harm_days int64 | time_to_detection_days int64 | economic_cost_direct_usd float64 | economic_cost_indirect_usd float64 | catastrophic_health_expenditure int64 | reported_to_authority int64 | legal_recourse int64 | compensation_received int64 | year int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9,901 | delayed | HARM_0231 | home | 8 | school_age | female | 0 | pneumonia | TB_medicine | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | mild | 1 | 7 | 0 | 0 | 0 | 1 | 4 | 9 | 1,027.04 | 1,112.22 | 1 | 0 | 0 | 0 | 2,024 |
9,902 | delayed | HARM_0278 | district_hospital | 27 | adult | male | 0 | diabetes | paediatric_syrup | substandard | 1 | formal_pharmacy | organ_damage_hepatotoxicity | life_threatening | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 2 | 1,567.18 | 787.15 | 1 | 0 | 0 | 0 | 2,023 |
9,903 | delayed | HARM_0285 | district_hospital | 26 | adult | female | 0 | infection_other | injectable | falsified | 0 | formal_pharmacy | prolonged_hospitalisation | life_threatening | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 23 | 1,163.34 | 836.37 | 1 | 0 | 0 | 0 | 2,022 |
9,904 | delayed | HARM_0193 | tertiary_hospital | 22 | adult | female | 0 | epilepsy | injectable | substandard | 0 | informal_market | antimicrobial_resistance_selection | severe | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 865.71 | 1,097.15 | 1 | 0 | 0 | 0 | 2,024 |
9,905 | delayed | HARM_0020 | community | 49 | adult | female | 0 | other | antibiotic | falsified | 0 | informal_market | antimicrobial_resistance_selection | severe | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 14 | 1,168.45 | 1,170.66 | 1 | 0 | 0 | 0 | 2,024 |
9,906 | delayed | HARM_0097 | home | 42 | adult | male | 0 | TB | antibiotic | falsified | 1 | donation | pregnancy_adverse_outcome | life_threatening | 1 | 1 | 1 | 0 | 0 | 1 | 4 | 13 | 1,319.19 | 1,647.91 | 1 | 0 | 0 | 0 | 2,021 |
9,907 | delayed | HARM_0263 | health_centre | 15 | adult | female | 0 | infection_other | herbal_traditional | falsified | 0 | informal_market | organ_damage_nephrotoxicity | fatal | 1 | 8 | 1 | 0 | 1 | 0 | 6 | 3 | 342.52 | 488.26 | 1 | 1 | 0 | 0 | 2,022 |
9,908 | delayed | HARM_0246 | community | 31 | adult | female | 0 | diarrhoea | TB_medicine | substandard | 0 | formal_pharmacy | allergic_anaphylactic_reaction | severe | 1 | 7 | 0 | 0 | 0 | 0 | 2 | 3 | 152.25 | 131.27 | 0 | 0 | 1 | 0 | 2,021 |
9,909 | delayed | HARM_0187 | health_centre | 39 | adult | male | 0 | infection_other | antimalarial | substandard | 0 | formal_pharmacy | prolonged_hospitalisation | life_threatening | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 11 | 110.39 | 117.79 | 0 | 0 | 0 | 0 | 2,022 |
9,910 | delayed | HARM_0082 | tertiary_hospital | 6 | school_age | female | 0 | infection_other | antimalarial | substandard | 0 | informal_market | death | mild | 1 | 9 | 0 | 0 | 0 | 0 | 18 | 2 | 116.48 | 209.83 | 0 | 0 | 0 | 0 | 2,024 |
9,911 | delayed | HARM_0015 | tertiary_hospital | 67 | elderly | female | 0 | diabetes | antihypertensive | substandard | 0 | informal_market | prolonged_hospitalisation | severe | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 58 | 2,031.73 | 2,893.64 | 1 | 0 | 0 | 0 | 2,023 |
9,912 | delayed | HARM_0015 | home | 23 | adult | female | 1 | pain_fever | ARV | substandard | 1 | informal_market | antimicrobial_resistance_selection | life_threatening | 1 | 1 | 0 | 0 | 0 | 1 | 14 | 16 | 126.5 | 97.32 | 0 | 0 | 1 | 0 | 2,024 |
9,913 | delayed | HARM_0159 | home | 24 | adult | male | 0 | malaria | paediatric_syrup | falsified | 0 | formal_pharmacy | organ_damage_nephrotoxicity | moderate | 1 | 9 | 0 | 0 | 0 | 1 | 7 | 5 | 206.34 | 103.17 | 0 | 0 | 0 | 0 | 2,021 |
9,914 | delayed | HARM_0194 | home | 27 | adult | female | 0 | pneumonia | antimalarial | substandard | 0 | formal_pharmacy | prolonged_hospitalisation | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 9 | 383.85 | 538.32 | 1 | 0 | 0 | 0 | 2,024 |
9,915 | delayed | HARM_0093 | community | 0 | neonate | female | 0 | hypertension | analgesic | substandard | 0 | online_purchase | organ_damage_nephrotoxicity | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 23 | 550.59 | 849.41 | 1 | 0 | 0 | 0 | 2,024 |
9,916 | delayed | HARM_0256 | private_clinic | 23 | adult | female | 0 | epilepsy | antimalarial | substandard | 0 | online_purchase | treatment_failure_disease_progression | fatal | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 5 | 853.81 | 1,772.44 | 1 | 0 | 0 | 0 | 2,020 |
9,917 | delayed | HARM_0240 | district_hospital | 3 | child | female | 0 | hypertension | antibiotic | substandard | 0 | formal_pharmacy | death | life_threatening | 1 | 13 | 0 | 0 | 0 | 0 | 5 | 17 | 178.42 | 243.86 | 0 | 0 | 0 | 0 | 2,022 |
9,918 | delayed | HARM_0139 | home | 4 | child | female | 0 | malaria | TB_medicine | substandard | 0 | online_purchase | treatment_failure_disease_progression | severe | 1 | 7 | 0 | 0 | 0 | 1 | 10 | 13 | 255.17 | 331.6 | 1 | 0 | 0 | 0 | 2,020 |
9,919 | delayed | HARM_0135 | community | 0 | neonate | male | 0 | epilepsy | antibiotic | substandard | 1 | informal_market | death | severe | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 271.06 | 494.6 | 1 | 0 | 0 | 0 | 2,021 |
9,920 | delayed | HARM_0104 | health_centre | 0 | neonate | male | 0 | pneumonia | antibiotic | substandard | 0 | online_purchase | treatment_failure_disease_progression | mild | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 6 | 60.34 | 80.27 | 0 | 0 | 0 | 0 | 2,021 |
9,921 | delayed | HARM_0169 | community | 67 | elderly | female | 0 | diabetes | herbal_traditional | substandard | 1 | formal_pharmacy | prolonged_hospitalisation | severe | 0 | 0 | 0 | 1 | 0 | 1 | 13 | 7 | 321.4 | 512.21 | 1 | 0 | 0 | 0 | 2,024 |
9,922 | delayed | HARM_0124 | health_centre | 4 | child | female | 0 | epilepsy | antimalarial | falsified | 1 | donation | acute_toxicity_poisoning | mild | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 278.18 | 434.3 | 1 | 0 | 0 | 0 | 2,023 |
9,923 | delayed | HARM_0165 | private_clinic | 8 | school_age | female | 0 | diabetes | antimalarial | falsified | 1 | formal_pharmacy | acute_toxicity_poisoning | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 12 | 1,365.28 | 1,380.04 | 1 | 0 | 0 | 0 | 2,022 |
9,924 | delayed | HARM_0098 | private_clinic | 0 | neonate | female | 0 | malaria | antibiotic | substandard | 1 | formal_pharmacy | treatment_failure_disease_progression | moderate | 1 | 2 | 0 | 0 | 0 | 0 | 6 | 7 | 294.55 | 390.81 | 1 | 0 | 0 | 0 | 2,023 |
9,925 | delayed | HARM_0231 | tertiary_hospital | 71 | elderly | female | 0 | infection_other | antibiotic | falsified | 0 | formal_pharmacy | acute_toxicity_poisoning | severe | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 151.41 | 231.9 | 0 | 0 | 0 | 0 | 2,023 |
9,926 | delayed | HARM_0160 | private_clinic | 18 | adult | female | 0 | diabetes | antimalarial | falsified | 1 | hospital_supply | disability_permanent | mild | 0 | 0 | 0 | 1 | 0 | 0 | 9 | 12 | 386.39 | 809.89 | 1 | 0 | 0 | 0 | 2,024 |
9,927 | delayed | HARM_0070 | community | 12 | school_age | female | 0 | other | TB_medicine | substandard | 0 | donation | neonatal_paediatric_harm | mild | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 494.68 | 768.62 | 1 | 0 | 0 | 0 | 2,021 |
9,928 | delayed | HARM_0151 | district_hospital | 23 | adult | male | 0 | diabetes | TB_medicine | substandard | 1 | formal_pharmacy | prolonged_hospitalisation | fatal | 1 | 1 | 1 | 0 | 1 | 1 | 11 | 1 | 3,356.06 | 5,470.04 | 1 | 0 | 0 | 0 | 2,021 |
9,929 | delayed | HARM_0166 | health_centre | 0 | neonate | male | 0 | infection_other | injectable | substandard | 1 | informal_market | organ_damage_hepatotoxicity | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 10 | 473.09 | 994.66 | 1 | 0 | 0 | 0 | 2,021 |
9,930 | delayed | HARM_0025 | district_hospital | 26 | adult | female | 0 | infection_other | ARV | falsified | 1 | formal_pharmacy | death | moderate | 1 | 1 | 0 | 0 | 0 | 0 | 19 | 4 | 609.73 | 1,196.33 | 1 | 0 | 0 | 0 | 2,024 |
9,931 | delayed | HARM_0098 | district_hospital | 26 | adult | female | 0 | infection_other | ARV | falsified | 0 | formal_pharmacy | neonatal_paediatric_harm | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 24 | 268.97 | 709.41 | 1 | 0 | 1 | 0 | 2,024 |
9,932 | delayed | HARM_0073 | health_centre | 26 | adult | female | 0 | TB | antibiotic | substandard | 0 | border_crossing | prolonged_hospitalisation | mild | 0 | 0 | 0 | 0 | 0 | 1 | 17 | 6 | 2,124.15 | 3,453.87 | 1 | 0 | 0 | 0 | 2,021 |
9,933 | delayed | HARM_0144 | tertiary_hospital | 23 | adult | female | 0 | malaria | antidiabetic | substandard | 0 | informal_market | prolonged_hospitalisation | fatal | 0 | 0 | 0 | 0 | 1 | 0 | 14 | 1 | 113.6 | 155.82 | 0 | 0 | 0 | 0 | 2,024 |
9,934 | delayed | HARM_0284 | private_clinic | 0 | neonate | female | 0 | diarrhoea | ARV | falsified | 0 | hospital_supply | organ_damage_hepatotoxicity | moderate | 1 | 6 | 0 | 0 | 0 | 0 | 44 | 8 | 829.21 | 926.82 | 1 | 0 | 0 | 0 | 2,021 |
9,935 | delayed | HARM_0273 | tertiary_hospital | 68 | elderly | male | 0 | pain_fever | antimalarial | falsified | 0 | online_purchase | acute_toxicity_poisoning | fatal | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 27 | 157.31 | 261.46 | 0 | 0 | 0 | 0 | 2,021 |
9,936 | delayed | HARM_0092 | health_centre | 46 | adult | male | 0 | pneumonia | ARV | substandard | 0 | informal_market | treatment_failure_disease_progression | mild | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 3 | 170.33 | 417.59 | 1 | 1 | 0 | 0 | 2,024 |
9,937 | delayed | HARM_0161 | private_clinic | 48 | adult | female | 0 | malaria | antihypertensive | falsified | 0 | informal_market | treatment_failure_disease_progression | severe | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 33 | 265.96 | 163.05 | 0 | 0 | 0 | 0 | 2,023 |
9,938 | delayed | HARM_0146 | tertiary_hospital | 8 | school_age | female | 0 | malaria | analgesic | substandard | 0 | informal_market | drug_interaction_toxicity | severe | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 0 | 476.27 | 615.26 | 1 | 0 | 0 | 0 | 2,021 |
9,939 | delayed | HARM_0142 | private_clinic | 26 | adult | male | 0 | hypertension | antibiotic | falsified | 0 | border_crossing | death | mild | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 31 | 542.94 | 717.75 | 1 | 0 | 0 | 0 | 2,022 |
9,940 | delayed | HARM_0070 | health_centre | 42 | adult | male | 0 | infection_other | antihypertensive | substandard | 0 | donation | organ_damage_hepatotoxicity | mild | 0 | 0 | 0 | 0 | 0 | 0 | 40 | 10 | 370.1 | 314.82 | 1 | 0 | 0 | 0 | 2,024 |
9,941 | delayed | HARM_0023 | health_centre | 0 | neonate | male | 0 | pneumonia | analgesic | substandard | 0 | hospital_supply | prolonged_hospitalisation | severe | 1 | 10 | 0 | 0 | 0 | 1 | 14 | 3 | 326.12 | 324.05 | 1 | 0 | 0 | 0 | 2,023 |
9,942 | delayed | HARM_0099 | home | 8 | school_age | female | 0 | hypertension | herbal_traditional | falsified | 0 | informal_market | treatment_failure_disease_progression | life_threatening | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 610.45 | 686.48 | 1 | 0 | 0 | 0 | 2,023 |
9,943 | delayed | HARM_0207 | home | 59 | elderly | male | 0 | diabetes | antibiotic | substandard | 1 | donation | organ_damage_nephrotoxicity | mild | 1 | 4 | 0 | 0 | 0 | 1 | 15 | 6 | 614.45 | 1,309.64 | 1 | 1 | 0 | 0 | 2,023 |
9,944 | delayed | HARM_0147 | district_hospital | 0 | neonate | male | 0 | diabetes | paediatric_syrup | substandard | 0 | donation | prolonged_hospitalisation | mild | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 5 | 1,390.16 | 1,927.08 | 1 | 0 | 0 | 0 | 2,021 |
9,945 | delayed | HARM_0252 | health_centre | 10 | school_age | female | 0 | malaria | ARV | substandard | 0 | formal_pharmacy | organ_damage_nephrotoxicity | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 346.31 | 270.48 | 1 | 0 | 0 | 0 | 2,022 |
9,946 | delayed | HARM_0153 | private_clinic | 44 | adult | female | 0 | malaria | TB_medicine | substandard | 0 | informal_market | death | severe | 1 | 2 | 0 | 0 | 0 | 1 | 8 | 5 | 339.47 | 251.14 | 1 | 0 | 0 | 0 | 2,022 |
9,947 | delayed | HARM_0161 | tertiary_hospital | 27 | adult | female | 1 | diabetes | antibiotic | substandard | 0 | formal_pharmacy | allergic_anaphylactic_reaction | fatal | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 1 | 246.24 | 518.18 | 1 | 0 | 0 | 0 | 2,023 |
9,948 | delayed | HARM_0080 | district_hospital | 42 | adult | female | 0 | epilepsy | antimalarial | substandard | 1 | online_purchase | treatment_failure_disease_progression | mild | 1 | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 340.04 | 524.53 | 1 | 0 | 0 | 0 | 2,022 |
9,949 | delayed | HARM_0256 | home | 67 | elderly | female | 0 | HIV | injectable | substandard | 1 | formal_pharmacy | treatment_failure_disease_progression | severe | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 265.87 | 238.83 | 1 | 0 | 1 | 0 | 2,022 |
9,950 | delayed | HARM_0127 | home | 5 | school_age | female | 0 | infection_other | antibiotic | falsified | 0 | formal_pharmacy | organ_damage_hepatotoxicity | moderate | 1 | 1 | 0 | 0 | 0 | 1 | 7 | 8 | 2,118.38 | 2,308.94 | 1 | 0 | 0 | 0 | 2,024 |
9,951 | delayed | HARM_0123 | community | 5 | school_age | male | 0 | HIV | injectable | falsified | 0 | informal_market | prolonged_hospitalisation | moderate | 1 | 2 | 0 | 1 | 0 | 0 | 2 | 10 | 447.12 | 949.63 | 1 | 0 | 0 | 0 | 2,024 |
9,952 | delayed | HARM_0210 | health_centre | 22 | adult | female | 0 | HIV | TB_medicine | falsified | 0 | formal_pharmacy | death | severe | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 3 | 106.6 | 117.64 | 0 | 0 | 0 | 0 | 2,020 |
9,953 | delayed | HARM_0213 | tertiary_hospital | 4 | child | female | 0 | hypertension | ARV | substandard | 0 | informal_market | acute_toxicity_poisoning | mild | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 5 | 431.94 | 588.85 | 1 | 1 | 0 | 0 | 2,023 |
9,954 | delayed | HARM_0092 | tertiary_hospital | 71 | elderly | male | 0 | other | antibiotic | substandard | 0 | formal_pharmacy | drug_interaction_toxicity | severe | 1 | 9 | 0 | 0 | 0 | 1 | 0 | 15 | 158.98 | 120.35 | 0 | 0 | 0 | 0 | 2,022 |
9,955 | delayed | HARM_0280 | community | 61 | elderly | female | 0 | epilepsy | analgesic | falsified | 1 | hospital_supply | allergic_anaphylactic_reaction | moderate | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 28 | 212.52 | 149.34 | 0 | 0 | 1 | 0 | 2,023 |
9,956 | delayed | HARM_0128 | private_clinic | 27 | adult | female | 0 | TB | analgesic | falsified | 0 | informal_market | organ_damage_hepatotoxicity | mild | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 14 | 185.93 | 330.86 | 1 | 0 | 0 | 0 | 2,023 |
9,957 | delayed | HARM_0149 | home | 46 | adult | male | 0 | epilepsy | TB_medicine | substandard | 0 | online_purchase | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 2 | 270.75 | 328.39 | 1 | 0 | 0 | 0 | 2,024 |
9,958 | delayed | HARM_0292 | district_hospital | 64 | elderly | female | 0 | malaria | antibiotic | substandard | 0 | hospital_supply | organ_damage_nephrotoxicity | moderate | 1 | 1 | 0 | 0 | 0 | 1 | 20 | 10 | 166.19 | 230.34 | 0 | 0 | 0 | 0 | 2,024 |
9,959 | delayed | HARM_0206 | community | 24 | adult | male | 0 | other | antimalarial | falsified | 1 | formal_pharmacy | drug_interaction_toxicity | severe | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 0 | 111.8 | 78.95 | 0 | 0 | 0 | 0 | 2,020 |
9,960 | delayed | HARM_0168 | private_clinic | 66 | elderly | male | 0 | HIV | antibiotic | substandard | 0 | informal_market | neonatal_paediatric_harm | life_threatening | 1 | 1 | 0 | 0 | 0 | 1 | 7 | 21 | 800.14 | 1,614.62 | 1 | 0 | 1 | 0 | 2,022 |
9,961 | delayed | HARM_0167 | community | 29 | adult | female | 0 | TB | antihypertensive | substandard | 0 | hospital_supply | antimicrobial_resistance_selection | life_threatening | 1 | 5 | 1 | 0 | 0 | 0 | 1 | 4 | 195.33 | 398.17 | 1 | 0 | 0 | 0 | 2,020 |
9,962 | delayed | HARM_0270 | health_centre | 0 | neonate | male | 0 | HIV | antibiotic | falsified | 0 | hospital_supply | treatment_failure_disease_progression | moderate | 1 | 3 | 0 | 0 | 0 | 0 | 2 | 23 | 206.2 | 466.15 | 1 | 1 | 0 | 0 | 2,021 |
9,963 | delayed | HARM_0167 | health_centre | 0 | neonate | female | 0 | hypertension | antihypertensive | substandard | 0 | informal_market | organ_damage_nephrotoxicity | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 1,059.32 | 1,915.68 | 1 | 0 | 0 | 0 | 2,021 |
9,964 | delayed | HARM_0022 | home | 27 | adult | female | 0 | other | ARV | substandard | 0 | formal_pharmacy | prolonged_hospitalisation | moderate | 1 | 18 | 0 | 0 | 0 | 0 | 34 | 10 | 475.8 | 767.66 | 1 | 0 | 0 | 0 | 2,020 |
9,965 | delayed | HARM_0228 | private_clinic | 62 | elderly | male | 0 | TB | paediatric_syrup | falsified | 0 | formal_pharmacy | disability_permanent | severe | 0 | 0 | 0 | 0 | 0 | 0 | 44 | 29 | 166.45 | 251.71 | 0 | 1 | 0 | 0 | 2,022 |
9,966 | delayed | HARM_0244 | district_hospital | 12 | school_age | male | 0 | diabetes | antibiotic | substandard | 0 | hospital_supply | organ_damage_hepatotoxicity | mild | 1 | 8 | 0 | 0 | 0 | 0 | 9 | 9 | 611.97 | 644.99 | 1 | 0 | 0 | 0 | 2,024 |
9,967 | delayed | HARM_0012 | health_centre | 3 | child | female | 0 | pain_fever | antihypertensive | substandard | 0 | formal_pharmacy | drug_interaction_toxicity | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 388.37 | 1,043.58 | 1 | 1 | 0 | 0 | 2,021 |
9,968 | delayed | HARM_0208 | private_clinic | 0 | neonate | male | 0 | diarrhoea | ARV | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | mild | 0 | 0 | 0 | 0 | 0 | 0 | 17 | 5 | 336.5 | 472.03 | 1 | 0 | 0 | 0 | 2,020 |
9,969 | delayed | HARM_0249 | tertiary_hospital | 28 | adult | female | 1 | pneumonia | analgesic | falsified | 0 | hospital_supply | prolonged_hospitalisation | moderate | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 8 | 582.4 | 564.62 | 1 | 0 | 0 | 0 | 2,023 |
9,970 | delayed | HARM_0146 | district_hospital | 25 | adult | male | 0 | other | injectable | substandard | 0 | informal_market | death | life_threatening | 1 | 10 | 1 | 0 | 0 | 1 | 3 | 2 | 712.25 | 593.66 | 1 | 0 | 0 | 0 | 2,024 |
9,971 | delayed | HARM_0100 | district_hospital | 17 | adult | female | 1 | malaria | antibiotic | substandard | 1 | informal_market | death | moderate | 1 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 1,007.69 | 1,719.04 | 1 | 0 | 0 | 0 | 2,024 |
9,972 | delayed | HARM_0110 | health_centre | 2 | child | female | 0 | HIV | herbal_traditional | substandard | 0 | formal_pharmacy | disability_permanent | severe | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 13 | 778.16 | 1,770.77 | 1 | 0 | 0 | 0 | 2,023 |
9,973 | delayed | HARM_0158 | district_hospital | 66 | elderly | female | 0 | other | antibiotic | substandard | 0 | formal_pharmacy | disability_permanent | severe | 0 | 0 | 0 | 0 | 0 | 1 | 18 | 0 | 342.57 | 476.84 | 1 | 0 | 0 | 0 | 2,023 |
9,974 | delayed | HARM_0104 | district_hospital | 21 | adult | male | 0 | hypertension | herbal_traditional | substandard | 0 | informal_market | treatment_failure_disease_progression | life_threatening | 1 | 4 | 1 | 0 | 0 | 1 | 1 | 15 | 390.4 | 642.32 | 1 | 0 | 0 | 0 | 2,021 |
9,975 | delayed | HARM_0028 | private_clinic | 63 | elderly | female | 0 | infection_other | antibiotic | falsified | 0 | formal_pharmacy | prolonged_hospitalisation | life_threatening | 1 | 1 | 1 | 0 | 0 | 1 | 12 | 15 | 248.92 | 433.24 | 1 | 0 | 0 | 0 | 2,024 |
9,976 | delayed | HARM_0001 | health_centre | 6 | school_age | male | 0 | infection_other | anticonvulsant | substandard | 0 | donation | antimicrobial_resistance_selection | moderate | 1 | 15 | 0 | 0 | 0 | 0 | 1 | 12 | 500.64 | 693.88 | 1 | 0 | 0 | 0 | 2,023 |
9,977 | delayed | HARM_0243 | health_centre | 8 | school_age | male | 0 | diarrhoea | ARV | falsified | 0 | border_crossing | organ_damage_hepatotoxicity | mild | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 7 | 383.55 | 191.78 | 1 | 0 | 0 | 0 | 2,022 |
9,978 | delayed | HARM_0109 | district_hospital | 46 | adult | female | 0 | epilepsy | TB_medicine | falsified | 1 | formal_pharmacy | allergic_anaphylactic_reaction | severe | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 27 | 717.52 | 1,453.66 | 1 | 1 | 1 | 0 | 2,024 |
9,979 | delayed | HARM_0207 | home | 22 | adult | female | 0 | malaria | ARV | substandard | 0 | donation | acute_toxicity_poisoning | fatal | 1 | 4 | 0 | 0 | 1 | 0 | 4 | 7 | 753.73 | 634.74 | 1 | 0 | 0 | 0 | 2,024 |
9,980 | delayed | HARM_0296 | private_clinic | 0 | neonate | female | 0 | epilepsy | anticonvulsant | substandard | 0 | formal_pharmacy | prolonged_hospitalisation | severe | 1 | 12 | 0 | 0 | 0 | 0 | 9 | 7 | 1,095.99 | 1,712.08 | 1 | 0 | 0 | 0 | 2,022 |
9,981 | delayed | HARM_0186 | home | 6 | school_age | male | 0 | hypertension | ARV | falsified | 0 | donation | antimicrobial_resistance_selection | moderate | 1 | 15 | 0 | 0 | 0 | 0 | 10 | 3 | 207.23 | 386.56 | 1 | 0 | 0 | 0 | 2,022 |
9,982 | delayed | HARM_0207 | district_hospital | 23 | adult | male | 0 | HIV | vaccine | substandard | 0 | informal_market | treatment_failure_disease_progression | severe | 1 | 11 | 0 | 0 | 0 | 1 | 8 | 23 | 376.36 | 221.26 | 1 | 0 | 0 | 0 | 2,024 |
9,983 | delayed | HARM_0006 | health_centre | 44 | adult | male | 0 | pneumonia | paediatric_syrup | falsified | 0 | formal_pharmacy | death | moderate | 1 | 5 | 0 | 0 | 0 | 0 | 5 | 8 | 503.65 | 540.79 | 1 | 0 | 0 | 0 | 2,023 |
9,984 | delayed | HARM_0016 | health_centre | 46 | adult | female | 0 | diabetes | antibiotic | falsified | 0 | informal_market | acute_toxicity_poisoning | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 252.67 | 417.9 | 1 | 0 | 1 | 0 | 2,024 |
9,985 | delayed | HARM_0014 | community | 46 | adult | male | 0 | TB | antihypertensive | substandard | 1 | hospital_supply | death | moderate | 0 | 0 | 0 | 0 | 0 | 1 | 11 | 8 | 252.67 | 212.14 | 0 | 0 | 0 | 0 | 2,022 |
9,986 | delayed | HARM_0187 | district_hospital | 49 | adult | female | 0 | HIV | ARV | substandard | 0 | formal_pharmacy | acute_toxicity_poisoning | moderate | 1 | 6 | 0 | 0 | 0 | 1 | 0 | 10 | 326.26 | 604.88 | 1 | 0 | 0 | 0 | 2,021 |
9,987 | delayed | HARM_0136 | district_hospital | 27 | adult | female | 0 | malaria | antibiotic | substandard | 0 | border_crossing | treatment_failure_disease_progression | mild | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 5 | 73.24 | 36.62 | 0 | 0 | 0 | 0 | 2,024 |
9,988 | delayed | HARM_0269 | private_clinic | 70 | elderly | female | 0 | other | antidiabetic | falsified | 0 | donation | death | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 1 | 598.01 | 1,122.76 | 1 | 0 | 0 | 0 | 2,021 |
9,989 | delayed | HARM_0206 | community | 45 | adult | female | 0 | pain_fever | anticonvulsant | falsified | 1 | donation | acute_toxicity_poisoning | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 17 | 264.21 | 445.2 | 1 | 0 | 0 | 0 | 2,023 |
9,990 | delayed | HARM_0128 | home | 20 | adult | male | 0 | other | TB_medicine | falsified | 1 | border_crossing | death | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 34 | 43 | 389.73 | 772.55 | 1 | 0 | 0 | 0 | 2,021 |
9,991 | delayed | HARM_0201 | community | 70 | elderly | female | 0 | malaria | herbal_traditional | substandard | 0 | online_purchase | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 4 | 305.03 | 301.07 | 1 | 0 | 0 | 0 | 2,020 |
9,992 | delayed | HARM_0160 | home | 62 | elderly | female | 0 | pneumonia | antibiotic | substandard | 0 | informal_market | treatment_failure_disease_progression | mild | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 11 | 102.14 | 109.52 | 0 | 0 | 0 | 0 | 2,021 |
9,993 | delayed | HARM_0076 | district_hospital | 26 | adult | male | 0 | pregnancy_complication | antihypertensive | substandard | 0 | hospital_supply | allergic_anaphylactic_reaction | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 994.58 | 2,022.76 | 1 | 0 | 0 | 0 | 2,023 |
9,994 | delayed | HARM_0140 | home | 2 | child | female | 0 | diarrhoea | antidiabetic | substandard | 0 | hospital_supply | acute_toxicity_poisoning | mild | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 10 | 443.63 | 918.58 | 1 | 0 | 0 | 0 | 2,023 |
9,995 | delayed | HARM_0080 | home | 39 | adult | male | 0 | diarrhoea | antimalarial | substandard | 0 | formal_pharmacy | neonatal_paediatric_harm | mild | 1 | 11 | 0 | 0 | 0 | 0 | 1 | 8 | 244.52 | 461.58 | 1 | 0 | 0 | 0 | 2,024 |
9,996 | delayed | HARM_0066 | community | 48 | adult | male | 0 | infection_other | antibiotic | falsified | 0 | informal_market | acute_toxicity_poisoning | mild | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 860.15 | 2,020.47 | 1 | 0 | 0 | 0 | 2,021 |
9,997 | delayed | HARM_0188 | community | 41 | adult | male | 0 | infection_other | vaccine | falsified | 0 | formal_pharmacy | prolonged_hospitalisation | severe | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 119.59 | 235.07 | 0 | 1 | 0 | 0 | 2,021 |
9,998 | delayed | HARM_0071 | community | 48 | adult | female | 0 | pain_fever | paediatric_syrup | substandard | 0 | hospital_supply | pregnancy_adverse_outcome | life_threatening | 1 | 2 | 0 | 1 | 0 | 1 | 5 | 1 | 278.83 | 282.4 | 1 | 0 | 1 | 0 | 2,024 |
9,999 | delayed | HARM_0195 | community | 23 | adult | female | 0 | hypertension | antimalarial | substandard | 0 | formal_pharmacy | organ_damage_nephrotoxicity | moderate | 0 | 0 | 0 | 1 | 0 | 0 | 10 | 12 | 1,657.6 | 3,045.09 | 1 | 0 | 0 | 0 | 2,022 |
10,000 | delayed | HARM_0061 | private_clinic | 27 | adult | female | 0 | epilepsy | anticonvulsant | substandard | 1 | informal_market | neonatal_paediatric_harm | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 19 | 25 | 421.53 | 468.34 | 1 | 0 | 1 | 0 | 2,020 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.